Lung Cancer Trial, Recruiting (NCT03791034)

Lung Cancer Trial, Recruiting NCT03791034 Sponsor: Samsung Medical Center Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03791034 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are willing and able to sign a consent form agreeing to take part in the trial
People who have non-small cell lung cancer that is either suspected based on a chest CT scan or confirmed by a tissue sample taken before surgery
People whose non-small cell lung cancer is confirmed by a tissue sample taken after surgery
People whose cancer is classified as stage I, II, or IIIA according to a standard cancer staging system (AJCC 7th edition)

Who may not be able to join:

People who have already received chemotherapy or radiation treatment for non-small cell lung cancer
People who have been diagnosed with any other type of cancer in the 3 years before joining the trial, except for certain skin cancers, thyroid cancer, or cervical cancer
People whose lung cancer has come back after previous treatment (recurrent lung cancer)
People whose cancer is classified as stage IIIB or stage IV according to the standard cancer staging system (AJCC 7th edition)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jhingook Kim, MD, Samsung Medical Center

Phone: +82-2-3410-3483

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03791034

Sponsor: Samsung Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

Trial contact: +82-2-3410-3483

More information: https://clinicaltrials.gov/study/NCT03791034

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are willing and able to sign a consent form agreeing to take part in the trial
People who have non-small cell lung cancer that is either suspected based on a chest CT scan or confirmed by a tissue sample taken before surgery
People whose non-small cell lung cancer is confirmed by a tissue sample taken after surgery
People whose cancer is classified as stage I, II, or IIIA according to a standard cancer staging system (AJCC 7th edition)

Who may not be able to join:

People who have already received chemotherapy or radiation treatment for non-small cell lung cancer
People who have been diagnosed with any other type of cancer in the 3 years before joining the trial, except for certain skin cancers, thyroid cancer, or cervical cancer
People whose lung cancer has come back after previous treatment (recurrent lung cancer)
People whose cancer is classified as stage IIIB or stage IV according to the standard cancer staging system (AJCC 7th edition)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Samsung Medical Center

Registry

ClinicalTrials.gov

Start date

28 August 2017

Est. completion

31 December 2021

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Recurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov